Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 14, 2024
Avantor, Inc. announced the opening of its new flagship Bridgewater Innovation Center. The state-of-the-art research and development facility, located in Bridgewater, NJ, is part of Avantor’s network of 13 research and innovation centers across the ...
read more
Experic announced a strategic collaboration with Flurry Powders to bring together complementary expertise to accelerate development of next generation therapies requiring advanced particle engineering.
read more
Charles River Laboratories International, an early-stage contract research organization (CRO), has extended its longstanding, strategic, integrated drug discovery partnership with Chiesi Farmaceutici SpA in the field of respiratory disease.
read more
AMRI will now offer its impurity solutions as a stand-alone service.
read more
As part of our public health mission, the FDA monitors the pharmaceutical supply chain to support patient access to medically necessary drugs.
read more
Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research organization (CRO), today announced two key executive promotions. Dave Bowser was promoted to Chief Operating Officer, leveraging his...
read more
Frontage Laboratories has entered into an agreement to acquire Quintara Discovery. The transaction is expected to close in the third quarter of 2021. Frontage Labs will finance the transaction through the Company's internal resources.
read more
ATCC has entered into an agreement with QIAGEN to provide them with sequencing data from its collection of cell lines, and animal and human biological materials. QIAGEN Digital Insights, the bioinformatics unit of QIAGEN, will establish a database ...
read more
Metabolon, Inc. has entered into an agreement with InnVentis Ltd. to apply metabolomics in individuals with chronic inflammatory diseases, such as rheumatoid arthritis. InnVentis aims to bring together multi-omics technologies with clinical data and ...
read more
Wednesday, September 20, 2017
Foreign Secretary Boris Johnson has officially opened TraceLink’s new European headquarters in Uxbridge, UK.
read more
Tuesday, November 20, 2018
Cambrex has entered into a definitive agreement to acquire Avista Pharma Solutions, a contract development, manufacturing, and testing organization, for approximately $252 million.
read more
Wednesday, March 31, 2021
Asymchem has announced a dedicated expansion of API manufacturing facilities to provide clients with peptide and oligonucleotide products.
read more
SPII is providing funding and other support to scientists at UCSF to accelerate the development of science inventions.
read more
Wednesday, August 08, 2018
This acquisition expands the U.S.-based analytical testing capabilities of Sotera Health’s Nelson Labs business.
read more
RedHill Biopharma has replaced its existing co-commercialization agreement with Daiichi Sankyo, for Movantik, which was assigned to RedHill under its April 2020 acquisition agreement with AstraZeneca.
read more